MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Deep brain stimulation enhances movement velocity during spiral drawing in Parkinson’s disease

    G. Gonzalez-Escamilla, M. Bange, D. Herz, G. Tinkhauser, M. Glaser, C. Ciolac, H. T, P. Brown, S. Groppa (Mainz, Germany)

    Objective: To investigate the relationship between subthalamic beta activity and hand drawing characteristics. Background: Parkinson’s disease (PD) affects various motor functions such as handwriting, walking,…
  • 2023 International Congress

    Efficacy and safety of deutetrabenazine in children and adolescents with dyskinesia in cerebral palsy

    D. Claassen, L. Dure, H. Barkay, S. Barash, G. Yiu, L. Voisin, L. Marinelli, P. Moshkov, J-M. Savola, M. Chen, N. Chaijale, M. Gordon, A. Ahn (Nashville, USA)

    Objective: To evaluate the efficacy and safety of deutetrabenazine (DTBZ) in children and adolescents with dyskinesia in cerebral palsy (DCP). Background: There are currently no…
  • 2023 International Congress

    Digital gait and turning impairments (quality but not quantity) during daily life are more severe in retrospective fallers compared to non-fallers with Parkinson’s disease

    V. Shah, C. Silva-Batista, P. Burgos, A. Ragothaman, P. Carlson-Kuhta, K. Sowalsky, F. Horak, M. Mancini (Porltand, USA)

    Objective: To investigate which specific digital gait and turning measures, obtained with body-worn sensors, best differentiate fallers from non-fallers with PD during daily life. Background:…
  • 2023 International Congress

    The East London Parkinson Disease Project – preliminary results from a diverse population

    A. Zirra, KC. Dey, E. Camboe, T. Haque, A. Ben-Joseph, J. Kahan, D. Gallagher, C. Budu, B. Huxford, C. Simonet, A. Lees, CR. Marshall, AJ. Noyce (London, United Kingdom)

    Objective: The East London Parkinson Disease (ELPD) project is a platform study to understand the manifestations and determinants of PD in a diverse population. Background:…
  • 2023 International Congress

    COVID-19 associated opsoclonus myoclonus ataxia syndrome

    K. Petrosyan, L. Martirosyan, A. Papoyan, A. Ashughyan, S. Voskanyan (Yerevan, Armenia)

    Objective: To present a rare neurological syndrome as a potential parainfectious complication of SARS-CoV-2 infection. Background: Օpsoclonus myoclonus syndrome (OMS) is rare complication of the…
  • 2023 International Congress

    Impaired mitochondrial respiration as a peripheral tissue biomarker for stratifying idiopathic Parkinson’s disease

    S. Kverneng, K. Stige, H. Berven, S. Mostafavi, M. Brischigliaro, B. Brakedal, G. Skeie, G. Nido, I. Flønes, E. Fernandez-Vizarra, C. Dölle, C. Tzoulis (Bergen, Norway)

    Objective: To determine whether structural and/or functional deficiencies of the mitochondrial respiratory chain (MRC) occur in the skeletal muscle of patients with idiopathic Parkinson’s disease…
  • 2023 International Congress

    The Parkinson’s Disease Composite of Executive-Functioning (PaCEF): A measure for detecting cognitive decline for Parkinson’s disease clinical trials

    C. Young, B. Cholerton, M. Shahid, C. Abdelnour, C. Zabetian, T. Montine, K. Poston (Stanford, USA)

    Objective: To develop a cognitive composite measure that is sensitive to decline in executive functioning for use in Parkinson’s disease (PD) clinical trials. Background: The…
  • 2023 International Congress

    Dry Cleaning Chemicals and Parkinson’s Disease

    M. Pawlik, S. Lettenberger, M. Zafar, P. Auinger, K. Hylton, M. Coffey, S. Goldman, B. de Miranda, K. Kieburtz, H. Schwarz, R. Barbano, M. Braun, J. Adams, D. Kinel, R. Dorsey (Rochester, USA)

    Objective: To characterize health outcomes of attorneys potentially exposed to dry cleaning chemicals. Background: Trichloroethylene (TCE), a chlorinated solvent used in dry cleaning and degreasing,…
  • 2023 International Congress

    Reduced non-REM sleep in Parkinson disease is associated with memory impairment and non-motor symptom burden

    S. Shah, C. Dintino, S. Lageman, N. Mukhopadhyay, E. Shelton, S. Holden, J. Broussard, L. Cloud, M. Barrett, B. Berman (Richmond, USA)

    Objective: To evaluate the relationship between sleep architecture and cognitive function in Parkinson disease (PD). Background: About half of PD patients develop mild cognitive impairment…
  • 2023 International Congress

    cerebellar cognitive affective syndrome is frequent in rfc1-related disorder

    C. Lobo, NB. Santos, F. Lima, T. Rezende, PC. Matos, JL. Pedroso, O. Barsottini, W. Marques Jr, M. França Jr (Campinas, Brazil)

    Objective: To describe the prevalence and clinical profile of cerebellar cognitive affective syndrome (CCAS) in patients with RFC1-related disorder. Background: Since the recent description of…
  • « Previous Page
  • 1
  • …
  • 75
  • 76
  • 77
  • 78
  • 79
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #25676 (not found)
  • Crack Dancing: An Uncommon Drug-Induced Chorea
  • #24376 (not found)
  • #24970 (not found)
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley